Worly, B. L., et al. “The Relationship Between Progestin Hormonal Contraception and Depression: A Systematic Review”. Contraception 97, no. 6 (2018): 478–89.

Yoto, A., et al. “Effects of L-Theanine or Caffeine Intake on Changes in Blood Pressure Under Physical and Psychological Stresses”. Journal of Physiological Anthropology 31 (2012): 28.

10. Поддержите свое либидо и репродуктивную функцию

Badawy, A., et al. “N-Acetylcysteine and Clomiphene Citrate for Induction of Ovulation in Polycystic Ovary Syndrome: A Cross-over Trial”. Acta Obstetricia et Gynecologica Scandinavica 86, no. 2 (2007): 218–22.

Baker, F. C., et al. “Circadian Rhythms, Sleep, and the Menstrual Cycle”. Sleep Medicine 8, no. 6 (2007): 613–22.

Bentzen, J. G., et al. “Ovarian Reserve Parameters: A Comparison Between Users and Non- users of Hormonal Contraception”. Reproductive BioMedicine Online 25, no. 6: 612–19.

Blackwell. “Oral Contraceptive Pill May Prevent More than Pregnancy: Could Cause Long- Term Problems with Testosterone”. ScienceDaily. January 5, 2006.

www.sciencedaily.com /releases/2006/01/060104232338.htm.

Bonnyns, M., et al. “Thyroid Gland and Female Sexual Function. I. Relation Outside of Pregnancy”. [In French.] Journal de Gynécologie, Obstétrique, et Biologie de la Reproduction 11, no. 4 (1982): 457–69.

Cheraghi, E., et al. “N-Acetylcysteine Improves Oocyte and Embryo Quality in Polycystic Ovary Syndrome Patients Undergoing Intracytoplasmic Sperm Injection: An Alternative to Metformin”. Reproduction, Fertility, and Development 28, no. 6 (2016): 723–31.

Coulam, C. B., et al. “Ultrasonographic Predictors of Implantation After Assisted Reproduction”. Fertility and Sterility 62, no. 5 (1994): 1004–10.

Cutler, W. B., et al. “Sexual Behavior Frequency and Biphasic Ovulatory Type Menstrual Cycles”. Physiology and Behavior 34, no. 5 (1985): 805–10.

Cutler, W. B., et al. “Sexual Behavior Frequency and Menstrual Cycle Length in Mature Premenopausal Women”. Psychoneuroendocrinology 4 (1979): 297–309.

https://www.athenainstitute.com/sciencelinks/sexualbehaviorfrequency1979.html.

De Flora, S., et al. “Attenuation of Influenza-like Symptomatology and Improvement of Cell- Mediated Immunity with Long-Term N-Acetylcysteine Treatment”. European Respiratory Journal 10, no. 7 (1977): 1535–41.

Deligdisch, L. “Hormonal Pathology of the Endometrium”. Modern Pathology 13, no. 3 (2000): 285–94.

Dewailly, D., et al. “The Physiology and Clinical Utility of Anti-Müllerian Hormone in Women”. Human Reproduction Update 20, no. 3 (2014): 370–85.

Dording, C. M., et al. “A Double-Blind Placebo-Controlled Trial of Maca Root as Treatment for Antidepressant-Induced Sexual Dysfunction in Women”. Evidence-Based Complementary and Alternative Medicine 2015 (2015): 949036.

Dorr, N. “Fertility Awareness and the Ovulation Method: Natural Birth Control”. Well-Being 35 (1978): 18–24.

Evans, J. L., et al. “The Molecular Basis for Oxidative Stress-Induced Insulin Resistance”. Antioxidants and Redox Signaling 7, nos. 7–8 (2005): 1040–52.

Fernando, S., et al. “Melatonin: Shedding Light on Infertility? – A Review of the Recent Literature”. Journal of Ovarian Research 7 (2014): 98.

Fouany, M. R., et al. “Is There a Role for DHEA Supplementation in Women with Diminished Ovarian Reserve?” Journal of Assisted Reproduction and Genetics 30, no. 9 (2013): 1239–44.

Fulghesu, A. M., et al. “N-Acetylcysteine Treatment Improves Insulin Sensitivity in Women with Polycystic Ovary Syndrome”. Fertility and Sterility 77, no. 6 (2002): 1128–35.

Gingnell, M., et al. “Oral Contraceptive Use Changes Brain Activity and Mood in Women with Previous Negative Affect on the Pill – A Double-Blinded, Placebo-Controlled Randomized Trial of a Levonorgestrel-Containing Combined Oral Contraceptive”. Psychoneuroendocrinology 38, no. 7 (2013): 1133–44.

Grow, D. R., et al. “Oral Contraceptives Maintain a Very Tin Endometrium Before Operative Hysteroscopy”. Fertility and Sterility 85, no. 1 (2006): 204–7.

Harvey, S. M. “Female Sexual Behavior: Fluctuations During the Menstrual Cycle”. Journal of Psychosomatic Research 31, no. 1 (1987): 101–10.

Hvidman, H. W., et al. “Anti-Müllerian Hormone Levels and Fecundability in Women with a Natural Conception”. European Journal of Obstetrics, Gynecology, and Reproductive Biology 217 (2017): 44–52.

Johnson, L. N., et al. “Antimüllerian Hormone and Antral Follicle Count Are Lower in Female Cancer Survivors and Healthy Women Taking Hormonal Contraception”. Fertility and Sterility 102, no. 3 (2014): 774–81.e3.

Kallio, S., et al. “Antimüllerian Hormone Levels Decrease in Women Using Combined Contraception Independently of Administration Route”. Fertility and Sterility 99, no. 5 (2013): 1305–10.

Kovacs, P., et al. “The Effect of Endometrial Thickness on IVF/ICSI Outcome”. Human Reproduction 18, no. 11 (2003): 2337–41.

Legros, J. J. “Inhibitory Effect of Oxytocin on Corticotrope Function in Humans: Are Vasopressin and Oxytocin Ying-Yang Neurohormones?” Psychoneuroendocrinology 26, no. 7 (2001): 649–55.

Lisofsky, N. “Hormonal Contraceptive Use Is Associated with Neural and Affective Changes in Healthy Young Women”. NeuroImage 134 (2016): 597–606.

Lorenz, T. K., et al. “Interaction of Menstrual Cycle Phase and Sexual Activity Predicts Mucosal and Systemic Humoral Immunity in Healthy Women”. Physiology and Behavior 152, pt. A (2015): 92–98.

Lorenz, T. K., et al. “Partnered Sexual Activity Moderates Menstrual Cycle – Related Changes in Inflammation Markers in Healthy Women: An Exploratory Observational Study”. Fertility and Sterility 107, no. 3 (2017): 763–73.e3.

Lorenz, T. K. A., et al. “Sexual Activity Modulates Shifts in TH1/TH2 Cytokine Profile Across the Menstrual Cycle: An Observational Study”. Fertility and Sterility 104, no. 6 (2015): 1513–21.e4.

Lorenz, T. K., et al. “Testosterone and Immune-Reproductive Tradeoffs in Healthy Women”. Hormones and Behavior 88 (2017): 122–130.

Magon, N., et al. “The Orgasmic History of Oxytocin: Love, Lust, and Labor”. Indian Journal of Endocrinology and Metabolism 15, suppl. 3 (2011): S156–61.

Masha, A., et al. “Prolonged Treatment with N-Acetylcysteine and L-Arginine Restores Gonadal Function in Patients with Polycystic Ovary Syndrome”. Journal of Endocrinological Investigation 32, no. 11 (2009): 870–72.

Montoya, E. R., et al. “How Oral Contraceptives Impact Social-Emotional Behavior and Brain Function”. Trends in Cognitive Sciences 21, no. 2 (2017): 125–36.

Nassaralla, C. L., et al. “Characteristics of the Menstrual Cycle After Discontinuation of Oral Contraceptives”. Journal of Women’s Health 20, no. 2 (2011): 169–77.